Publications by authors named "Stephen Arcona"

Claim this Profile
A
A Comprehensive Review of Methods to Measure Oral Oncolytic Dose Intensity Using Retrospective Data.
Julia F Slejko, Juan-David Rueda, James A Trovato, Emily F Gorman, Gail Betz, Stephen Arcona

J Manag Care Spec Pharm· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis.
Minlei Liao, Yunfeng Li, Farid Kianifard, Engels Obi, Stephen Arcona

BMC Nephrol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing patient participation in drug development.
Paul Wicks, Maria Lowe, Susan Gabriel, Slaven Sikirica, Rahul Sasane, Stephen Arcona

Nat Biotechnol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease.
Tzy-Chyi Yu, Huanxue Zhou, Kangho Suh, Stephen Arcona

Clinicoecon Outcomes Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia.
Junji Lin, Yunfeng Li, Haijun Tian, Michael J Goodman, Susan Gabriel, Stephen Arcona

Clinicoecon Outcomes Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric-coated mycophenolate sodium versus mycophenolate mofetil maintenance immunosuppression: outcomes analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network database.
William Irish, Stephen Arcona, Ryan J Gifford, G Mark Baillie, Matthew Cooper

Transplantation· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.
Matthew Cooper, Kathleen L Deering, Douglas P Slakey, Qing Harshaw, Stephen Arcona

Transplantation· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.
Ross J Baldessarini, Leslie Leahy, Stephen Arcona, Douglas Gause, Winnie Zhang

Psychiatr Serv· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of the occupational disruptiveness scale of the neuropsychiatric inventory-nursing home version to measure the impact of rivastigmine on the disruptive behavior of nursing home residents with Alzheimer's disease.
Hind T Hatoum, Swu-Jane Lin, Stephen Arcona, Simu K Thomas, Barbara Koumaras

J Am Med Dir Assoc· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease.
Dong-Churl Suh, Simu K Thomas, Elmira Valiyeva, Stephen Arcona, Lien Vo

Drugs Aging· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rivastigmine use on the risk of nursing home placement in a US sample.
Kathleen M Beusterien, Simu K Thomas, Douglas Gause, Miriam Kimel, Stephen Arcona

CNS Drugs· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of hypertension control in a primary care setting.
Thomas G Majernick, Christopher Zacker, Nancy A Madden, Daniel A Belletti, Stephen Arcona

Am J Hypertens· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
Dong-Churl Suh, Stephen Arcona, Simu K Thomas, Christopher Powers, Adrian L Rabinowicz

Drugs Aging· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal adverse events in a general population sample of nursing home residents taking cholinesterase inhibitors.
Anthony Hughes, Jonathan Musher, Simu K Thomas, Kathleen M Beusterien, Bill Strunk, Stephen Arcona

Consult Pharm· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia.
Roger D Luo, Daniel A Belleti, Dung Tran, Stephen Arcona, Philip N Salen

Int J Psychiatry Med· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving guideline compliance: assessment of unit-based reminder for monitoring platelet counts post-PCI.
Daniel Belletti, Robert B Bolash, Stephen Arcona, James F Reed

J Healthc Qual· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis